These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 26517011)
1. Tailoring sub-micron PLGA particle release profiles via centrifugal fractioning. Dutta D; Salifu M; Sirianni RW; Stabenfeldt SE J Biomed Mater Res A; 2016 Mar; 104(3):688-696. PubMed ID: 26517011 [TBL] [Abstract][Full Text] [Related]
2. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles. Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568 [TBL] [Abstract][Full Text] [Related]
3. [Preparation of alginate-chitosan-poly (lactic-co-glycolic acid) composite microsphere and its regulation of protein release]. Zheng CH; Liang WQ; Yu HY Yao Xue Xue Bao; 2005 Feb; 40(2):182-6. PubMed ID: 15875679 [TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres. Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028 [TBL] [Abstract][Full Text] [Related]
5. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization. Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589 [TBL] [Abstract][Full Text] [Related]
6. Co-encapsulation of human serum albumin and superparamagnetic iron oxide in PLGA nanoparticles: part II. Effect of process variables on protein model drug encapsulation efficiency. Shubhra QT; Feczkó T; Kardos AF; Tóth J; Mackova H; Horak D; Dósa G; Gyenis J J Microencapsul; 2014; 31(2):156-65. PubMed ID: 23875617 [TBL] [Abstract][Full Text] [Related]
7. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides. Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294 [TBL] [Abstract][Full Text] [Related]
8. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH; Taluja A; Knutson K; Han Bae Y J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769 [TBL] [Abstract][Full Text] [Related]
9. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer. Ray S; Ghosh Ray S; Mandal S Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352 [TBL] [Abstract][Full Text] [Related]
10. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification. Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891 [TBL] [Abstract][Full Text] [Related]
12. Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles. Okassa LN; Marchais H; Douziech-Eyrolles L; Hervé K; Cohen-Jonathan S; Munnier E; Soucé M; Linassier C; Dubois P; Chourpa I Eur J Pharm Biopharm; 2007 Aug; 67(1):31-8. PubMed ID: 17289360 [TBL] [Abstract][Full Text] [Related]
13. Biodegradable nanoparticles for protein delivery: analysis of preparation conditions on particle morphology and protein loading, activity and sustained release properties. Coleman J; Lowman A J Biomater Sci Polym Ed; 2012; 23(9):1129-51. PubMed ID: 21639993 [TBL] [Abstract][Full Text] [Related]
14. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S; Faraj J; DeLuca P Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159 [TBL] [Abstract][Full Text] [Related]
15. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters. Chaisri W; Ghassemi AH; Hennink WE; Okonogi S Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499 [TBL] [Abstract][Full Text] [Related]
16. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Chu CH; Wang YC; Huang HY; Wu LC; Yang CS Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related]
18. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques. Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795 [TBL] [Abstract][Full Text] [Related]
19. Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion. Yuan W; Wu F; Guo M; Jin T Eur J Pharm Sci; 2009 Feb; 36(2-3):212-8. PubMed ID: 18832030 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]